CP
CPRX

CenterBook Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

CenterBook Partners’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Buy
+57,723
New +$1.7M 0.09% 251
2026
Q1 		– Sell
-48,464
Closed -$1.13M – 676
2025
Q4 		$1.13M Buy
48,464
+36,556
+307% +$814K 0.06% 347
2025
Q3 		$235K Sell
11,908
-3,031
-20% -$62.3K 0.01% 536
2025
Q2 		$324K Buy
+14,939
New +$353K 0.02% 481
2023
Q4 		– Sell
-13,577
Closed -$159K – 408
2023
Q3 		$159K Buy
13,577
+2,259
+20% +$30.2K 0.02% 403
2023
Q2 		$152K Buy
+11,318
New +$163K 0.02% 397
2022
Q4 		– Sell
-26,231
Closed -$337K – 396
2022
Q3 		$337K Buy
+26,231
New +$311K 0.07% 325

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CenterBook Partners's CPRX Position: Q2 2026 in Review

CenterBook Partners opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 57,723 shares worth $1.81M. The stake represents 0.09% of the portfolio and ranks #251 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in CPRX as recently as Q4 2025.

CenterBook Partners first reported a position in CPRX in Q3 2022 and has held it in 7 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • CenterBook Partners held 57,723 shares of Catalyst Pharmaceutical worth $1.81M as of Q2 2026.
  • Catalyst Pharmaceutical was a new CenterBook Partners position in Q2 2026.
  • Catalyst Pharmaceutical made up 0.09% of CenterBook Partners's portfolio in Q2 2026, its #251 holding.
  • CenterBook Partners first reported a position in Catalyst Pharmaceutical in Q3 2022 and has held it in 7 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.